Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer

被引：156
|
作者：
Kaira, K. [1 ,2 ]
Sunose, Y. [3 ]
Arakawa, K. [4 ]
Ogawa, T. [4 ]
Sunaga, N. [1 ]
Shimizu, K. [3 ]
Tominaga, H. [5 ]
Oriuchi, N. [6 ]
Itoh, H. [7 ]
Nagamori, S. [8 ]
Kanai, Y. [8 ]
Segawa, A. [2 ]
Furuya, M. [2 ]
Mori, M. [1 ]
Oyama, T. [2 ]
Takeyoshi, I. [3 ]
机构：
[1] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 3718511, Japan
[2] Gunma Univ, Grad Sch Med, Dept Diagnost Pathol, Maebashi, Gunma 3718511, Japan
[3] Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Organ Surg, Maebashi, Gunma 3718511, Japan
[4] Maebashi Red Cross Hosp, Dept Surg, Maebashi, Gunma, Japan
[5] Gunma Univ, Grad Sch Med, Dept Mol Imaging, Maebashi, Gunma 3718511, Japan
[6] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 3718511, Japan
[7] Maebashi Red Cross Hosp, Dept Pathol, Maebashi, Gunma, Japan
[8] Osaka Univ, Grad Sch Med, Div Biosyst Pharmacol, Osaka, Japan
来源：
BRITISH JOURNAL OF CANCER | 2012年 / 107卷 / 04期
关键词：
LAT1; CD98; pancreatic cancer; amino-acid transporter; prognostic factor; Ki-67; THYMIC EPITHELIAL TUMORS; LYMPH-NODE METASTASES; CELL LUNG-CANCER; CD98; EXPRESSION; DUCTAL ADENOCARCINOMA; LAT1; CARCINOMA; SURVIVAL; ANGIOGENESIS; MALIGNANCY;
D O I：
10.1038/bjc.2012.310
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
BACKGROUND: The expression of L-type amino-acid transporter 1 (LAT1) is tumour-specific and has been shown to have essential roles in cell growth and survival. However, little is known regarding the clinical significance of LAT1 expression in pancreatic cancer. This study was conducted to determine the prognostic significance of LAT1 expression. METHODS: A total of 97 consecutive patients with surgically resected pathological stage I-IV pancreatic ductal adenocarcinoma were retrospectively reviewed. Tumour sections were stained by immunohistochemistry for LAT1, CD98, Ki-67 and vascular endothelial growth factor (VEGF), and microvessel density was determined by CD34 and p53. RESULTS: L-type amino-acid transporter 1 and CD98 were highly expressed in 52.6% (51/97) and 56.7% (55/97) of cases, respectively (P = 0.568). The expression of LAT1 within pancreatic cancer cells was significantly associated with disease stage, tumour size, Ki-67, VEGF, CD34, p53 and CD98. L-type amino-acid transporter 1 expression was confirmed to be a significant prognostic factor for predicting poor outcome by multivariate analysis. CONCLUSION: L-type amino-acid transporter 1 expression is a promising pathological marker for the prediction of outcome in patients with pancreatic cancer. British Journal of Cancer (2012) 107, 632-638. doi:10.1038/bjc.2012.310 www.bjcancer.com Published online 17 July 2012 (C) 2012 Cancer Research UK
引用
收藏
页码：632 / 638
页数：7
相关论文
共 50 条
  • [31] Immunohistochemical expression of L-type amino acid transporter 1(LAT1) for human breast cancer
    Uchigasaki, S
    Sakamoto, A
    JOURNAL OF PATHOLOGY, 2002, 198 : 57A - 57A
  • [32] Expression of L-type amino acid transporter 1 in canine and feline intracranial tumors
    Utsugi, Shinichi
    Ogihara, Kikumi
    Naya, Yuko
    Sunden, Yuji
    Nakamoto, Yuya
    Okamoto, Yoshiharu
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2022, 84 (08): : 1111 - 1117
  • [33] The L-type Amino Acid Transporter (LAT1) Expression in Patients with Scoliosis
    Demura, Satoru
    Hinoi, Eiichi
    Kawakami, Noriaki
    Handa, Makoto
    Yokogawa, Noriaki
    Hiraiwa, Manami
    Kato, Satoshi
    Shinmura, Kazuya
    Shimizu, Takaki
    Oku, Norihiro
    Annen, Ryohei
    Kobayashi, Motoya
    Yamada, Yohei
    Nagatani, Satoshi
    Iezaki, Takashi
    Taniguchi, Yuki
    Tsuchiya, Hiroyuki
    SPINE SURGERY AND RELATED RESEARCH, 2022, 6 (04): : 402 - 407
  • [34] High expression of L-type amino acid transporter 1 in infiltrating glioma cells
    Nawashiro H.
    Otani N.
    Uozumi Y.
    Ooigawa H.
    Toyooka T.
    Suzuki T.
    Katoh H.
    Tsuzuki N.
    Ohnuki A.
    Shima K.
    Shinomiya N.
    Matsuo H.
    Kanai Y.
    Brain Tumor Pathology, 2005, 22 (2) : 89 - 91
  • [35] Clinicopathological Significance of L-type Amino Acid Transporter 1 (LAT1) Expression in Patients with Adenoid Cystic Carcinoma
    Kaira, Kyoichi
    Toyoda, Minoru
    Shino, Masato
    Sakakura, Koichi
    Takahashi, Katsumasa
    Tominaga, Hideyuki
    Oriuchi, Noboru
    Kanai, Yoshikatsu
    Oyama, Tetsunari
    Chikamatsu, Kazuaki
    PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (04) : 649 - 656
  • [36] Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma
    Kobayashi, H
    Ishii, Y
    Takayama, T
    JOURNAL OF SURGICAL ONCOLOGY, 2005, 90 (04) : 233 - 238
  • [37] Expression of L-type amino acid transporter 1 is a poor prognostic factor for Non-Hodgkin's lymphoma
    Jigjidkhorloo, Narangerel
    Kanekura, Kohsuke
    Matsubayashi, Jun
    Akahane, Daigo
    Fujita, Koji
    Oikawa, Keiki
    Kurata, Atsushi
    Takanashi, Masakatsu
    Endou, Hitoshi
    Nagao, Toshitaka
    Gotoh, Akihiko
    Norov, Oyundelger
    Kuroda, Masahiko
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [38] Expression of L-type amino acid transporter 1 is a poor prognostic factor for Non-Hodgkin’s lymphoma
    Narangerel Jigjidkhorloo
    Kohsuke Kanekura
    Jun Matsubayashi
    Daigo Akahane
    Koji Fujita
    Keiki Oikawa
    Atsushi Kurata
    Masakatsu Takanashi
    Hitoshi Endou
    Toshitaka Nagao
    Akihiko Gotoh
    Oyundelger Norov
    Masahiko Kuroda
    Scientific Reports, 11
  • [39] L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapy
    Hayashi, Keitaro
    Anzai, Naohiko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2022, 148 (01) : 31 - 40
  • [40] Potential Biomarker of L-type Amino Acid Transporter 1 in Breast Cancer Progression
    Liang Z.
    Cho H.T.
    Williams L.
    Zhu A.
    Liang K.
    Huang K.
    Wu H.
    Jiang C.
    Hong S.
    Crowe R.
    Goodman M.M.
    Shim H.
    Nuclear Medicine and Molecular Imaging, 2011, 45 (2) : 93 - 102
12345